Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.
Clinical trial NCT00258765 · TERMINATED
Trial details
- NCT number
- NCT00258765
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2006-11-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.